Recombinant Human Arginase 1/ARG1 Protein, CF

R&D Systems | Catalog # 5868-AR

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems E. coli-derived Recombinant Human Arginase 1/ARG1 Protein (5868-AR)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession Number

P05089

Structure / Form

Monomer

Applications

Enzyme Activity
View all Arginase 1/ARG1 Proteins and Enzymes »

Product Specifications

Source

E. coli-derived human Arginase 1/ARG1 protein
Met1-Lys322 with an N-terminal Met and 6-His tag

Purity

>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met

Predicted Molecular Mass

36 kDa

SDS-PAGE

40 kDa, reducing conditions

Activity

Measured by the production of urea during the hydrolysis of arginine.
The specific activity is >35,000 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation, and Storage

5868-AR
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl, Glycerol and DTT.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.

Background: Arginase 1/ARG1

Arginase 1, also known as liver arginase, is a binuclear manganese metalloenzyme. It is a key enzyme of the urea cycle that catalyses the conversion of L-arginine into L-ornithine and urea, the final cytosolic reaction of urea formation in the mammalian liver (1). Arginase 1 is abundantly expressed in liver, but it is also expressed in cells and tissues that lack a complete urea cycle, including lung. Arginase is a critical regulator of nitric oxide synthesis and vascular function (2). It is implicated in a variety of human diseases including vascular disease, pulmonary disease, infectious disease, immune cell function and cancer (3). In humans, hereditary defects in arginase result in an accumulation of arginine in the blood known as hyperarginemia (4). Arginase deficiency can also result in the accumulation of nitrogen in the form of ammonia, which results in hyperammonemia (5).

References

  1. Dowling, D. et al. (2008) Cell Mol. Life Sci. 65:2039.
  2. Durante, W. et al. (2007) Clin. Exp. Pharmacol. Physiol. 34:906.
  3. Morris, S. (2009) Br. J. Pharmacol. 157:922.
  4. Crombez, E. et al. (2005) Mol. Genet. Metab. 84:243.
  5. Scaglia, F. et al. (2004) J. Nutr. 134:2775s.

Long Name

Liver-Type Arginase

Alternate Names

AI, ARG1, Arginase-1, Liver Arginase, PGIF, Type I Arginase

Entrez Gene IDs

383 (Human); 11846 (Mouse); 29221 (Rat)

Gene Symbol

ARG1

UniProt

P05089

Additional Arginase 1/ARG1 Products

Product Documents for Recombinant Human Arginase 1/ARG1 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human Arginase 1/ARG1 Protein, CF

For research use only

Citations for Recombinant Human Arginase 1/ARG1 Protein, CF

Customer Reviews for Recombinant Human Arginase 1/ARG1 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Arginase 1/ARG1 Protein, CF and earn rewards!

Have you used Recombinant Human Arginase 1/ARG1 Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Arginase 1/ARG1 Protein, CF (5868-AR):

Materials
  • Assay Diluent: Deionized Water
  • Recombinant Human Arginase 1/ARG1 (rhARG1) (Catalog # 5868-AR)
  • Substrate Buffer: 125 mM L-Arginine, 625 mM Glycine, pH 10.5
  • Manganese Choride, 1 M stock in deionized water
  • o-Phthaldialdehyde (oPA), (Sigma, Catalog # P0657), 50 mg/mL (373 mM) stock in DMSO
  • N-(1-Naphthyl)ethylene-diamine dihydrochloride (NED) (Sigma, Catalog # N9125), 500 mM stock in DMSO
  • 50 mM Boric Acid, 1 M Sulfuric Acid, 0.03% Brij-35 (w/v) [Caution: highly acidic, neutralize before disposal]
  • Urea, 100 mM stock in deionized water
  • 96-well Clear Plate (Costar, Catalog # 92592)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Dilute rhARG1 to 0.25 µg/mL in deionized water.
  2. Prepare a standard curve from the 100 mM Urea stock. Dilute 100 µL of 100 mM Urea with 900 µL of deionized water to make a 10 mM Urea solution. Use this for the first point of the curve.
  3. Perform six additional one-half serial dilutions of the 10 mM Urea stock in deionized water. The standard curve has a range of 7813 to 500,000 pmol per well.
  4. Load 50 µL of each dilution of the standard curve into a plate. Include a blank containing only deionized water.
  5. Load 40 µL of the 0.25 µg/mL rhARG1 into the plate. Load multiple wells as some will be used as enzyme blanks.
  6. From the Substrate Buffer and Manganese Chloride stocks, prepare a solution of 100 mM Arginine, 500 mM Glycine, 1.25 mM MnCl2, pH 10.5. Do not prepare this solution until immediately before use as the manganese will gradually precipitate out of solution.
  7. Add 10 µL of 100 mM Arginine, 500 mM Glycine, 1.25 mM MnCl2, pH 10.5 to the wells containing 0.25 µg/mL rhARG1 (exclude the blanks). Mix well.
  8. Cover the plate and incubate at 37 °C for two hours.
  9. Dilute oPA stock to 4 mM in 50 mM Boric Acid, 1 M Sulfuric Acid, 0.03% Brij-35 (w/v).
  10. Dilute NED stock to 4 mM in 50 mM Boric Acid, 1 M Sulfuric Acid, 0.03% Brij-35 (w/v).
  11. Combine equal volumes of 4 mM oPA and 4 mM NED to form a solution of 2 mM oPA with 2 mM NED.
  12. Add 200 µL of the 2 mM oPA, 2 mM NED solution to all wells, including the standard curve.
  13. Prepare a fresh solution of 100 mM Arginine, 500 mM Glycine, 1.25 mM MnCl2, pH 10.5. Add 10 µL to each well used as an enzyme blank.
  14. Cover the plate and incubate at room temperature for 20 minutes.
  15. Read plate at 520 nm (absorbance) in endpoint mode.
  16. Calculate specific activity:

    17.      Specific Activity (pmol/min/µg) =

    		 Adjusted Urea Detected* (OD)
    Incubation time (min) x amount of enzyme (µg)

     *Derived from the urea standard curve using linear or 4-parameter fitting and adjusted for Substrate Blank.

Per Well:
  • rhARG1: 0.01 µg (10 ng)
  • Arginine: 4 mM
  • oPA & NED: 1.6 mM
  • Urea Curve: 500000, 250000, 125000, 62500, 31250, 15625 and 7813 pmol

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes